Angiopoietin-like protein 8/betatrophin as a new determinant of type 2 diabetes remission after bariatric surgery by Ejarque, Miriam, Borlaug, Marianne, Vilarrasa, Nuria, Martinez-Perez, Bruno, Llauradó, Gemma, Megía, Ana, Helland, Thomas, Gutierrez, Cristina, Serena, Carolina, Folkestad, Oddry, Nuñez-Roa, Catalina, Roche, Kelly, Casajoana, Ana, Fradera, Rosa, González-Clemente, José Miguel, López, Miguel, Mohn, Arne C., Nedrebø, Bjørn G., Nogueiras, Ruben, Mellgren, Gunnar, Fernø, Johan, Fernández-Veledo, Sonia, Vendrell, Joan

Get full text

ANGPTL8 as a new determinant of type 2 diabetes remission after bariatric surgery by Ejarque, Miriam, Borlaug, Marianne, Vilarrasa, Nuria, Martinez-Perez, Bruno, Llauradó, Gemma, Megía, Ana, Helland, Thomas, Gutierrez, Cristina, Serena, Carolina, Folkestad, Oddry, Nuñez-Roa, Catalina, Roche, Kelly, Casajoana, Ana, Fradera, Rosa, González-Clemente, José Miguel, López, Miguel, Mohn, Arne C, Nedrebø, Bjørn G, Nogueiras, Ruben, Mellgren, Gunnar, Fernø, Johan, Fernández-Veledo, Sonia, Vendrell, Joan

Get full text

Once-weekly semaglutide in heart failure with preserved ejection fraction and obesity: main results from the STEP-HFpEF trial by Sindone, Andrew, Kosiborod, Mikhail, Abildstrøm, Steen Z, Borlaug, Barry A, Butler, Javed, Rasmussen, Søren, Davies, Melanie J, Hovingh, G. Kees, Kitzman, Dalane W, Lindegaard, Marie L, Møller, Daniél Vega, Shah, Sanjiv J, Treppendahl, Marianne Bach, Verma, Subodh, Petrie, Mark C

Get full text

Once-weekly semaglutide in patients with heart failure with preserved ejection fraction, obesity and type 2 diabetes: main results from the STEP-HFpEF DM trial by Sindone, Andrew, Kosiborod, Mikhail, Petrie, Mark C, Borlaug, Barry A, Butler, Javed, Davies, Melanie J, Hovingh, G. Kees, Kitzman, Dalane W, Møller, Daniél Vega, Treppendahl, Marianne Bach, Verma, Subodh, Jensen, Thomas J, Liisberg, Karoline, Lindegaard, Marie L, Shah, Sanjiv J

Get full text

211 - Once-weekly semaglutide in patients with heart failure with preserved ejection fraction, obesity and type 2 diabetes: main results from the STEP-HFpEF DM trial by Sindone, Andrew, Kosiborod, Mikhail, Petrie, Mark C, Borlaug, Barry A, Butler, Javed, Davies, Melanie J, Hovingh, G. Kees, Kitzman, Dalane W, Møller, Daniél Vega, Treppendahl, Marianne Bach, Verma, Subodh, Jensen, Thomas J, Liisberg, Karoline, Lindegaard, Marie L, Shah, Sanjiv J

Get full text

210 - Once-weekly semaglutide in heart failure with preserved ejection fraction and obesity: main results from the STEP-HFpEF trial by Sindone, Andrew, Kosiborod, Mikhail, Abildstrøm, Steen Z, Borlaug, Barry A, Butler, Javed, Rasmussen, Søren, Davies, Melanie J, Hovingh, G. Kees, Kitzman, Dalane W, Lindegaard, Marie L, Møller, Daniél Vega, Shah, Sanjiv J, Treppendahl, Marianne Bach, Verma, Subodh, Petrie, Mark C

Get full text